Dynavax's Z-1018 shingles vaccine matched Shingrix in immune response with fewer side effects, advancing to Phase 2 in older adults in 2025.

Shares of Dynavax rose after the company released positive results from a trial of its shingles vaccine tested against current Shingles vaccine Shingrix. The stock was up 6.7% to $11.12 but is still ...

Dynavax’s lofty ambition to snatch Shingrix’s crown got off to a promising start after the biopharma’s investigational shingles vaccine held its own against GSK’s mainstay in the first part of a phase ...

Dynavax Technologies Corp. (DVAX) on Thursday said that its experimental Shingles vaccine yielded positive results in an ...

Dynavax Technologies (NASDAQ:DVAX) added ~7% in the premarket on Thursday after the company said that its experimental ...

Shingles Vaccine Shortage: What You Must Know Because of high demand, Shingrix, the two-dose vaccine approved in 2017 to prevent shingles and its blistery skin rash, continues to be in short sup ...

Shingrix's efficacy rate is more than 90%, according to GSK. Experts recommend anyone who wants Shingrix to get on the waitlist at a pharmacy, clinic or doctor's office.

Shingrix, the new shingles vaccine, is over 90 percent effective in preventing the painful viral infection Julie Mazziotta is the Senior Sports Editor at PEOPLE, covering everything from the NFL ...

Shingrix is contraindicated for immunocompromised adults with a history of severe allergies, anaphylaxis, or those with prior vaccine-related adverse reactions, according to the vaccine's label.

If you’re 50 or older, Judith Strull's story might sound familiar. Told by her doctor last month to get the new shingles vaccine, Shingrix, she went to her local CVS in Newton, Mass., expecting ...

She was able to get the popular new shingles vaccine, Shingrix, at her Rite Aid pharmacy in Taylor without having to go on a waiting list. "I am a Type-2 diabetic, so it’s good for me to do the ...